Lee, M H <br/><br/>
Combination chemotherapy with Clostridium perfringens phospholipase C and cytosine antimetabolites: complementary inhibition directed at membrane lipids.  [electronic resource] 

 -  Cancer drug delivery  1983 
 - 21-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-9482 
<br/><br/><label>Standard No.: </label>10.1089/cdd.1983.1.21  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Azacitidine--administration & dosage<br/>Cell Line<br/>Choline--metabolism<br/>Clostridium--enzymology<br/>Cytarabine--administration & dosage<br/>Leukemia L1210--drug therapy<br/>Membrane Lipids--metabolism<br/>Mice<br/>Microscopy, Electron, Scanning<br/>Sarcoma 180--drug therapy<br/>Type C Phospholipases--administration & dosage